CBLL
Ceribell, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$24.31
−1.66%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.50
- Revenue estimate
- $29.2M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.51
- EPS estimate
- -$0.47
- Revenue actual
- $28.1M
- Revenue estimate
- $27.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.0%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $28
- PT range
- $26 – $30
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.47 | -$0.51 | Miss -8.24% | $28.1M |
| May 11, 2026 | -$0.39 | -$0.52 | Miss -33.33% | $26.5M |
| Feb 24, 2026 | -$0.43 | -$0.36 | Beat 15.48% | $24.8M |
| Nov 4, 2025 | -$0.43 | -$0.37 | Beat 13.95% | $22.6M |
| May 8, 2025 | -$0.43 | -$0.36 | Beat 16.28% | $20.5M |
| Oct 11, 2024 | — | -$1.59 | — | $14.9M |
| Mar 31, 2024 | — | -$1.59 | — | $14.9M |
| Dec 31, 2023 | — | -$0.35 | — | $13.1M |
| Sep 30, 2023 | — | -$0.30 | — | $11.6M |
| Jun 30, 2023 | — | -$1.35 | — | $10.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026